Medical AI Alliance
← Company Index
Pharma & CDMOKOSDAQ 068760288 approvals70 trials

Celltrion Pharm Inc.

Official website

Celltrion Pharm holds exclusive domestic distribution rights for 12 Celltrion biologics and manufactures the liver drug Godex.

As of 2026-10-10, Celltrion Pharm Inc. has 2 Korean MFDS device approvals, 286 Korean MFDS drug approvals, 3 PubMed-indexed papers on record (counted by the MAA Company Index from its own matching of public databases).

Price

Change

Market cap

Business overview

Source: DART corporate disclosure

Founded in 2000, Celltrion Pharm listed on KOSDAQ in 2006 and holds exclusive domestic distribution rights for biologics developed by parent company Celltrion. It manufactures chemical drugs including the liver treatment Godex at its Jincheon and Ochang facilities, and sells 12 biologics domestically: Remsima, Remsima SC, Yuflyma, Steqeyma, and Aptozma for autoimmune diseases; Truxima, Herzuma, and Vegzelma for oncology; and Stoboclo and Osenvelt for bone disease. Cumulative sales reached about KRW 536.4 billion (up 12.3% YoY), with chemical drugs at KRW 200.6 billion (+7.8%), biologics at KRW 130.6 billion (+50.8%), and service revenue at KRW 124.3 billion (+13.1%).

Products & technology

  • Godex
  • 램시마
  • 램시마SC
  • 유플라이마
  • 스테키마
  • 앱토즈마
  • 트룩시마
  • 허쥬마
  • 베그젤마
  • 스토보클로
  • 오센벨트

Regulatory approvals

data.go.kr

286 Korean MFDS drug approvals · 1983–2026 / 2 Korean MFDS device approvals · 2019

  • MFDS drugZafatek Tablets 100mg(Trelagliptin Succinate)2026-07-30
    Drug · Prescription · Approval202602208
  • MFDS drugCellrozet OD Tab. 10/20mg2026-06-30
    Drug · Prescription · Approval202601894
  • MFDS drugCellrozet OD Tab. 10/10mg2026-06-30
    Drug · Prescription · Approval202601895
  • MFDS drugCellrozet OD Tab. 10/5mg2026-06-30
    Drug · Prescription · Approval202601896
  • MFDS drugVonocell Tab. 20mg (vonoprazan)2026-05-27
    Drug · Prescription · Approval202601511
  • MFDS drugVonocell Tab. 10mg (vonoprazan)2026-05-27
    Drug · Prescription · Approval202601512
  • MFDS drugMemotin Tab. 5mg2025-12-05
    Drug · Prescription · Approval202503175
  • MFDS drugCellmitri Tab.80/5/25mg2025-12-04
    Drug · Prescription · Approval202503162
  • MFDS drugCellmitri Tab. 80/5/12.5mg2025-12-04
    Drug · Prescription · Approval202503163
  • MFDS drugCellmitri Tab.40/5/12.5mg2025-12-04
    Drug · Prescription · Approval202503164
  • MFDS drugCelltozet Tab. 10/5mg2025-11-27
    Drug · Prescription · Approval202503098
  • MFDS drugCellmisartan Tab. 20mg2025-07-31
    Drug · Prescription · Approval202501998
Show 68 more
  • MFDS drugCelltafen Cap.2025-07-11
    Drug · Prescription · Approval202501758
  • MFDS drugActosmet 15/850mg2025-03-20
    Drug · Prescription · Approval202500638
  • MFDS drugMemotin Tab. 20mg2025-02-25
    Drug · Prescription · Approval202500399
  • MFDS drugAmrozet tablet 10/20/10mg2024-11-27
    Drug · Prescription · Approval202402806
  • MFDS drugAmrozet tablet 10/5/10mg2024-11-27
    Drug · Prescription · Approval202402807
  • MFDS drugAmrozet tablet 5/10/10mg2024-11-27
    Drug · Prescription · Approval202402808
  • MFDS drugAmrozet tablet 5/5/10mg2024-11-27
    Drug · Prescription · Approval202402809
  • MFDS drugAmrozet tablet 5/20/10mg2024-11-27
    Drug · Prescription · Approval202402810
  • MFDS drugAmrozet tablet 10/10/10mg2024-11-27
    Drug · Prescription · Approval202402811
  • MFDS drugCell-Q-ramin Tab. 240mg2024-11-11
    Drug · OTC · Notification202402663
  • MFDS drugEdarbi Tablets 20mg(Azilsartan Medoxomil Potassium)2024-05-08
    Drug · Prescription · Approval202401116
  • MFDS drugEdarbyclor Tablets 40/12.5mg2024-04-25
    Drug · Prescription · Approval202400975
  • MFDS drugEdarbyclor Tablets 40/25mg2024-04-25
    Drug · Prescription · Approval202400976
  • MFDS drugNesinaAct Tablets 25/15mg2023-12-28
    Drug · Prescription · Approval202303455
  • MFDS drugNesinaAct Tablets 25/30mg2023-12-28
    Drug · Prescription · Approval202303456
  • MFDS drugNesinaMet Tablets 12.5/1000mg2023-12-28
    Drug · Prescription · Approval202303457
  • MFDS drugNesinaMet Tablets 12.5/850mg2023-12-28
    Drug · Prescription · Approval202303458
  • MFDS drugNesinaMet Tablets 12.5/500mg2023-12-28
    Drug · Prescription · Approval202303459
  • MFDS drugEdarbi Tablets 40mg(Azilsartan Medoxomil Potassium)2023-12-22
    Drug · Prescription · Approval202303419
  • MFDS drugEdarbi Tablets 80mg(Azilsartan Medoxomil Potassium)2023-12-22
    Drug · Prescription · Approval202303420
  • MFDS drugCelltrion Azilsartan Clo Tab. 40/25mgRevoked2023-11-02
    Drug · Prescription · Approval202303055
  • MFDS drugCelltrion Azilsartan Clo Tab. 40/12.5mgRevoked2023-11-01
    Drug · Prescription · Approval202303041
  • MFDS drugNesina Tablets 12.5mg2023-10-30
    Drug · Prescription · Approval202303030
  • MFDS drugNesina Tablets 25mg2023-10-30
    Drug · Prescription · Approval202303031
  • MFDS drugCelltrion Alogliptin Met Tab. 12.5/1000mgRevoked2023-09-21
    Drug · Prescription · Approval202302795
  • MFDS drugCelltrion Alogliptin Met Tab. 12.5/500mgRevoked2023-09-21
    Drug · Prescription · Approval202302796
  • MFDS drugNesinaMet XR Tab. 25/1000mg2023-09-14
    Drug · Prescription · Approval202302753
  • MFDS drugNesinaMet XR Tab. 12.5/500mg2023-09-14
    Drug · Prescription · Approval202302754
  • MFDS drugNesinaMet XR Tab. 12.5/1000mg2023-09-14
    Drug · Prescription · Approval202302755
  • MFDS drugCelltrion Azilsartan Medoxomil Tab. 40mgRevoked2023-08-31
    Drug · Prescription · Approval202302595
  • MFDS drugCelltrion Azilsartan Medoxomil Tab. 80mgRevoked2023-08-31
    Drug · Prescription · Approval202302596
  • MFDS drugOseni 25/30 mg Tab.Revoked2023-07-07
    Drug · Prescription · Approval202302076
  • MFDS drugOseni 25/15 mg Tab.Revoked2023-07-06
    Drug · Prescription · Approval202302067
  • MFDS drugCelltrion Alo Tab. 12.5mgRevoked2023-06-08
    Drug · Prescription · Approval202301785
  • MFDS drugCelltrion Alo Tab. 25mgRevoked2023-06-08
    Drug · Prescription · Approval202301786
  • MFDS drugGodex Max Tab.2023-05-10
    Drug · Prescription · Approval202301516
  • MFDS drugCelltamet Tablet 50/850mgRevoked2022-01-19
    Drug · Prescription · Approval202200319
  • MFDS drugCelltamet Tablet 50/500mgRevoked2022-01-19
    Drug · Prescription · Approval202200320
  • MFDS drugCelltamet Tablet 50/1000mgRevoked2022-01-19
    Drug · Prescription · Approval202200321
  • MFDS drugCellpaem tab. 25mg2021-08-11
    Drug · Prescription · Approval202105907
  • MFDS drugCellpaem tab. 10mg2021-08-11
    Drug · Prescription · Approval202105908
  • MFDS drugDeferasirox Tab. 360mg (for export)Revoked2021-05-18
    Drug · Prescription · Approval202103968
  • MFDS drugDeferasirox Tab. 180mg (for export)Revoked2021-05-18
    Drug · Prescription · Approval202103969
  • MFDS drugDeferasirox Tab. 90mg (for export)Revoked2021-05-18
    Drug · Prescription · Approval202103970
  • MFDS drugDapacell Tab. 5mgRevoked2021-02-04
    Drug · Prescription · Approval202101088
  • MFDS drugDapacell Tab. 10mgRevoked2021-02-04
    Drug · Prescription · Approval202101089
  • MFDS drugIMMUTHERA Tab.2021-01-20
    Drug · Prescription · Approval202100575
  • MFDS drugCelltozet Tab. 10/20mg2021-01-08
    Drug · Prescription · Approval202100211
  • MFDS drugCelltozet Tab. 10/10mg2021-01-08
    Drug · Prescription · Approval202100212
  • MFDS drugCelltozet Tab. 10/40mgRevoked2021-01-08
    Drug · Prescription · Approval202100210
  • MFDS drugRocellmetec Tablets 20/10mgRevoked2020-10-30
    Drug · Prescription · Approval202007465
  • MFDS drugCelltrion Famotidine Tab. 20mg (for export)Revoked2020-10-07
    Drug · Prescription · Approval202006818
  • MFDS drugCelltrion Famotidine Tab. 40mg (for export)Revoked2020-10-07
    Drug · Prescription · Approval202006819
  • MFDS drugGlustop Tab. 45mg (for export)Revoked2020-10-06
    Drug · Prescription · Approval202006757
  • MFDS drugGlustop Tab. 30mg (for export)Revoked2020-10-05
    Drug · Prescription · Approval202006725
  • MFDS drugGlustop Tab. 15mg (for export)Revoked2020-10-05
    Drug · Prescription · Approval202006726
  • MFDS drugIMMUTHERA Tab. 25 mg2020-08-18
    Drug · Prescription · Approval202005873
  • MFDS drugCellsita Tablets 50mg(Sitagliptin Hydrochloride Hydrate)Revoked2020-08-18
    Drug · Prescription · Approval202005877
  • MFDS drugCellsita Tablets 25mg(Sitagliptin Hydrochloride Hydrate)Revoked2020-08-18
    Drug · Prescription · Approval202005878
  • MFDS drugCellsita Tablets 100mg(Sitagliptin Hydrochloride Hydrate)Revoked2020-08-18
    Drug · Prescription · Approval202005879
  • MFDS drugLyfrega Cap. 50mg (for export)Revoked2020-06-05
    Drug · Prescription · Approval202004249
  • MFDS drugLyfrega Cap. 75mg (for export)Revoked2020-06-05
    Drug · Prescription · Approval202004250
  • MFDS drugLyfrega Cap. 100mg (for export)Revoked2020-06-05
    Drug · Prescription · Approval202004251
  • MFDS drugLyfrega Cap. 150mg (for export)Revoked2020-06-05
    Drug · Prescription · Approval202004252
  • MFDS drugTamsol SR Tab. 0.2mg2020-04-24
    Drug · Prescription · Approval202002981
  • MFDS drugTamsol SR Tab. 0.4mg2020-04-24
    Drug · Prescription · Approval202002985
  • MFDS drugVenaclean SR Tab. 300mg2020-04-08
    Drug · Prescription · Approval202002487
  • MFDS drugCeperisone SR Tab.2020-02-14
    Drug · Prescription · Approval202000960

Showing the 80 most recent of 288 records.

Clinical trials

data.go.kr

70 MFDS clinical trial authorisations · 2012–2026 (Bioequivalence 61 · Phase 1 6 · Phase 3 2 · Phase 4 1)

  • Phase 1CTPH-D0052026-03-09

    1 trial site

  • BioequivalenceCTP-D003-T2025-11-19

    2 trial sites

  • Phase 1CT-K20022022-03-22

    2 trial sites

  • Bioequivalence에소졸정40밀리그램(에스오메프라졸마그네슘삼수화물)2022-02-09

    2 trial sites

  • Bioequivalence셀미스타정80/5밀리그램2021-11-08

    2 trial sites

  • Phase 3CT-K2002R1, CT-K2002R22021-10-06

    30 trial sites

  • Bioequivalence칸타칸플러스정16/12.5밀리그램2021-08-23

    2 trial sites

  • Phase 1CT-K20022021-06-08

    2 trial sites

  • Bioequivalence에소졸정40밀리그램(에스오메프라졸마그네슘삼수화물)2021-05-25

    2 trial sites

  • Bioequivalence팜시비르정250밀리그램(팜시클로비르)2021-05-25

    2 trial sites

  • Bioequivalence칸타칸정16밀리그램(칸데사르탄실렉세틸)2021-03-19

    2 trial sites

  • Phase 1CT-K2002R1, CT-K2002R22020-07-21

    2 trial sites

Show 58 more
  • Bioequivalence셀토젯정10/40밀리그램2020-02-26

    2 trial sites

  • Phase 4네시나액트정25/15밀리그램,네시나액트정25/30밀리그램, 메트그린에스알정500밀리그람2019-10-08

    33 trial sites

  • Phase 3CTP-JB022019-04-24

    25 trial sites

  • Bioequivalence칸타칸정16밀리그램(칸데사르탄실렉세틸)2016-02-19

    2 trial sites

  • Bioequivalence글루스탑정(피오글리타존염산염)2016-02-05

    2 trial sites

  • Bioequivalence레바트정(레바미피드)2016-02-05

    1 trial site

  • Bioequivalence모사핀정(모사프리드시트르산염수화물)2016-02-05

    2 trial sites

  • Bioequivalence엑시프로정20밀리그램(에스시탈로프람옥살산염)2016-02-03

    2 trial sites

  • Bioequivalence토파스정100밀리그램(토피라메이트)2016-02-01

    2 trial sites

  • Bioequivalence판토라정40밀리그램(판토프라졸나트륨세스키히드레이트)2016-01-13

    2 trial sites

  • Bioequivalence셀트리온클래리트로마이신정500밀리그램2016-01-07

    2 trial sites

  • Bioequivalence이토칸정50밀리그램(이토프리드염산염)2015-12-08

    2 trial sites

  • Bioequivalence클로피스정75밀리그램(클로피도그렐황산염)2015-12-03

    2 trial sites

  • Bioequivalence트리푸칸-포르테캡슐(플루코나졸)50mg2015-11-27

    2 trial sites

  • Bioequivalence딜카롤정25밀리그램(카르베딜롤)2015-11-27

    2 trial sites

  • Bioequivalence세록세틴정20밀리그램(파록세틴염산염수화물)2015-11-27

    2 trial sites

  • Bioequivalence셀트리온레보플록사신정100mg2015-11-27

    2 trial sites

  • Bioequivalence잘레톤정(잘토프로펜)2015-11-27

    1 trial site

  • Bioequivalence지니패스정4밀리그램(실로도신)2015-11-27

    2 trial sites

  • Bioequivalence루미신정150밀리그램(록시트로마이신)2015-11-27

    2 trial sites

  • Bioequivalence시리우스정100밀리그램(실데나필시트르산염)2015-11-26

    2 trial sites

  • Bioequivalence뉴란자핀정10밀리그램(올란자핀)2015-11-26

    2 trial sites

  • Bioequivalence테라루신정2밀리그램(테라조신염산염수화물)2015-11-26

    2 trial sites

  • Bioequivalence리프레가캡슐150밀리그램(프레가발린)2015-11-25

    2 trial sites

  • Bioequivalence아잘틴정(아젤라스틴염산염)2015-11-16

    2 trial sites

  • Bioequivalence피타로정2밀리그램(피타바스타틴칼슘)2015-11-16

    1 trial site

  • Bioequivalence알레제로정10밀리그램(에피나스틴염산염)2015-11-13

    2 trial sites

  • Bioequivalence프바로틴정40밀리그램(프라바스타틴나트륨)2015-11-03

    2 trial sites

  • Bioequivalence뉴로가펜캡슐400밀리그램(가바펜틴)2015-11-02

    2 trial sites

  • Bioequivalence조이클로버정400밀리그램(아시클로비르)2015-11-02

    1 trial site

  • Bioequivalence스톨라푸정10밀리그램(라푸티딘)2015-11-02

    2 trial sites

  • Bioequivalence알레네정70밀리그램(알렌드론산나트륨)2015-11-02

    2 trial sites

  • Bioequivalence알레네플러스정2015-11-02

    2 trial sites

  • Bioequivalence피타로정4밀리그램(피타바스타틴칼슘)2015-10-29

    1 trial site

  • Bioequivalence셀트린정50밀리그램(설트랄린염산염)2015-10-29

    2 trial sites

  • Bioequivalence프레로타정100밀리그램(실로스타졸)2015-10-28

    1 trial site

  • Bioequivalence실로넥신정2015-10-28

    1 trial site

  • Bioequivalence타올라스정20밀리그램(타다라필)2015-10-16

    2 trial sites

  • Bioequivalence마루틴정150mg(라니티딘염산염)2015-10-14

    2 trial sites

  • Bioequivalence메로빅캡슐15밀리그램(멜록시캄)2015-10-13

    1 trial site

  • Bioequivalence록소디펜정(록소프로펜나트륨수화물)2015-10-13

    1 trial site

  • Bioequivalence토바스틴정80밀리그램(아토르바스타틴칼슘삼수화물)2015-08-28

    2 trial sites

  • Bioequivalence레비탐정1000밀리그램(레비티라세탐)2015-08-27

    2 trial sites

  • Bioequivalence아리프라정10밀리그램(아리피프라졸)2015-08-25

    2 trial sites

  • Bioequivalence알츠필정(도네페질염산염)2015-08-25

    2 trial sites

  • Bioequivalence글리메정4밀리그램(글리메피리드)2015-08-24

    1 trial site

  • Bioequivalence리스포돈정1밀리그램(리스페리돈)2015-08-24

    2 trial sites

  • Bioequivalence크로스틴정10밀리그램(로수바스타틴칼슘)2015-08-24

    2 trial sites

  • Bioequivalence세레브캡슐200밀리그램(세레콕시브)2015-08-17

    2 trial sites

  • Bioequivalence셀미살탄80밀리그램(텔미사르탄)2015-08-17

    2 trial sites

  • Bioequivalence몬테라정10밀리그램(몬테루카스트나트륨)2015-08-17

    2 trial sites

  • Bioequivalence셀메텍정20밀리그램(올메사르탄메독소밀)2015-08-13

    2 trial sites

  • Bioequivalence이무테라정(아자티오프린)2015-07-24

    2 trial sites

  • Bioequivalence코살정100밀리그램(로사르탄칼륨)2015-06-30

    2 trial sites

  • Bioequivalence코살정100밀리그램(로사르탄칼륨)2015-02-24

    2 trial sites

  • Bioequivalence암로디핀베실산염2015-01-20

    2 trial sites

  • Phase 1피페라진다이치옥트산정2012-12-12

    1 trial site

  • Phase 1피페라진다이치옥트산정2012-08-30

    1 trial site

Global clinical trials

ClinicalTrials.gov · sponsor-matched

R&D and key agreements

Source: DART corporate disclosure

복합제 개량신약 및 글로벌 제네릭 개발 · 연구개발 단계 · R&D division at the Global Biotechnology Research Center in Songdo, Incheon is expanding the improved-drug pipeline; 59 researchers including 15 PhDs and 38 master's-degree holders

Key disclosures

KRX KIND via OpenDART

Publications

PubMed · affiliation-matched

Patents

KIPRIS · applicant-matched
Show 39 more patents

AI reads

MAA server logs · IP-verified
42
Times AI engines pulled Celltrion Pharm Inc.'s records

Pulled records become part of each AI's index and keep feeding its answers. When an AI cites from that index, nothing reaches our server — so actual citations are uncounted here and exceed this number.

1
Fetched fresh mid-answer

Times an AI needed something not yet in its index and fetched this page fresh while answering. Citations served from the index leave no trace here.

41
Index crawls

Collected as raw material for future answers.

0
Direct AI-tool queries (MCP)

Queries from users who connected this index to their own AI.

5
live 0
Last 7 days
31
live 1
Last 30 days
42
live 1
All time
  • OpenAIChatGPT-Userlive1
  • OpenAIOAI-SearchBot33
  • PerplexityPerplexityBot4
  • AnthropicClaudeBot2
  • MicrosoftBingbot1
  • GoogleGoogleOther1

Measured since Aug 27, 2026 · 5 AI engines · last read Oct 9, 2026

User-agent strings can be forged, so we do not count them at face value. We count only requests matched against vendor-published IP ranges, or confirmed by forward-verified reverse DNS. MCP queries are actual calls to this index's tool endpoint.

Connect this index to your AI tool →

Connect this company index directly to your AI

Connect it to ChatGPT or Claude, and your AI queries the full record — profiles, financials, stock data, regulatory approvals, clinical trials, publications and patents — for Celltrion Pharm Inc. and every listed Korean medical, bio and AI company.

How to connect (MCP)
Not yet compiled: business overview. Send us materials and we will add them

Companies approved for the same productsPharma & CDMO

Ranked by how many MFDS product categories overlap. Not a ranking — a pointer to where to look.

Boditech Med Inc.1 shared

KOSDAQ-listed point-of-care immunodiagnostics company supplying diagnostic cartridges and the ichroma/AFIAS instrument series.

DAEWON PHARMACEUTICAL CO.,LTD1 shared

KOSPI-listed pharmaceutical company behind Coldwon cold medicine and Jangdaewon probiotics, developing a P-CAB drug pipeline.

DONG-A ST CO.,LTD1 shared

Dong-A ST, spun off from Dong-A Socio Holdings in 2013 and KOSPI-listed, makes prescription drugs like Growtropin, Stillen, and Bacchus.

ILDONG HOLDINGS CO.,LTD100

Founded in 1941 and listed on the KOSPI in 1975, Ildong Holdings is the holding company of the Ildong Pharmaceutical Group, overseeing pharmaceutical, aesthetic medical device, and drug development affiliates.

Yuyu Pharma, Inc.100

Founded in 1941 and listed on the KOSPI in 1975, Yuyu Pharma is a pharmaceutical company with a co-promotion agreement with Dong-A ST for Tanamin.

IL DONG PHARMACEUTICAL CO., LTD.100

Founded and listed on the KOSPI in 2016, Il Dong Pharmaceutical manufactures products including the Aronamin vitamin line.

Medy-Tox Inc.99

Founded 2000, KOSDAQ-listed 2009, Medy-Tox develops and exports botulinum toxin biopharmaceuticals including Meditoxin and Innotox.

GC Biopharma Corp.97

KOSPI-listed comprehensive pharmaceutical company specializing in blood products and vaccines, with FDA-approved immunoglobulin ALYGLO.

SAMSUNG BIOLOGICS CO.,LTD.85

Founded 2011, listed 2016 — Samsung Biologics is a biopharma CDMO with 785,000L capacity across five Songdo plants.

GENOLUTION INC.85

Founded in 2006 and listed on KOSDAQ in 2020, Genolution is a molecular diagnostics and RNAi company producing nucleic acid extraction reagents and devices.

AHN-GOOK PHARMACEUTICAL Co., Ltd.85

Ahn-Gook Pharmaceutical sells the cough/expectorant drug Sinecuran and the eye-health supplement Tobicom.

CORESTEMCHEMON Inc.85

Founded in 2003 and listed on KOSDAQ in 2015, Corestem Chemon develops stem cell therapies and provides nonclinical CRO services, including the ALS treatment Neuronata-R.

Sources and updates

Counts on this page are not company-reported figures. MAA matched records from DART, the Korean MFDS, the US FDA, ClinicalTrials.gov, PubMed and KIPRIS to this company itself, by business registration number or registered name, never by name similarity. They may differ from figures the company publishes.

Company basics
Korea Exchange · DART
Business content
Compiled from disclosure filings
Approvals & clinical trials
Korean MFDS (data.go.kr) · US FDA openFDA — updated weekly
Key disclosures
KRX KIND via OpenDART exchange filings — updated daily
Global clinical trials
ClinicalTrials.gov (US NIH) — sponsor-matched, updated weekly
Financials
DART corporate disclosure filings — annual
Publications
PubMed (US National Library of Medicine) — affiliation-matched, updated daily
Patents
KIPRIS (Korea Institute of Patent Information) — applicant-matched, updated monthly
AI reads
Our server logs, IP-verified every 6 hours
AI visibility
Measured 2026-10-01

This page is compiled from public sources without the company's involvement. If anything is inaccurate or incomplete, please let us know. Materials provided by the company are labelled as such.

Request a correction or addition